Programme

Thursday, 7^th May 2015

 

17.00  – 17.15	Tea/Coffee, Poster viewing
17.30  – 17.50	GSK State of the Art Presentation Dr. Corklin Steinhart, Head of Global Medical Directors, GSK/ViiV Healthcare
17.50 – 18.30	Ebola – the UK Experience Dr. Michael Jacobs, Royal Free Hospital, London
18.30 – 20.00	SpR Presentations

Friday, 8^th May 2015

 

08.30 – 09.30	BMS Sponsored Symposium:    Dr Isabelle Klauck,  BMS WW Medical Director, Virology;  Prof. Soo Aleman, Karolinska Institute, Sweden
09.30 – 09.35	Meeting Opening – Dr. Patrick Mallon, President, IDSI
09.35 – 10.15	Pre-Exposure Prophylaxis for HIV Prof. Sheena McCormack, Senior Clinical Scientist, MRC Clinical Trials Unit, University College London
10.15 – 10.30	Renal dysfunction is associated with increased bone turnover in HIV infected patients – Elena Alvarez
10.30 – 10.45	Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative subjects – Dr. Patrick Mallon
10.45 – 11.00	Tenofovir Alafenamide (TAF) in a Single Tablet Regimen in Initial HIV-1 Therapy – Dr. Paul Benn
11.00 – 11.15	Coffee/Tea, Poster Viewing
11.15 – 12.00	The Economic Impact of New HCV Treatments Prof. Yazdan Yazdanpanah, Professor of Infectious Disease, Bichat Hospital, ATIP-Avenir INSERM, Paris Diderot University
12.00 – 12.15	Outcomes of HCV treatment in HIV co-infected patients in the pre-DAA era: 2001-2012 – Dr. Ciaran Bannan
12.15 – 12. 30	Hepatitis C virus NS3 and NS5A drug resistance mutations in treatment-naïve chronically-infected individuals in Ireland – Dr. Cillian de Gascun
12.30 – 12.45	Patient Characteristics associated with Non-Engagement in Hepatitis C (HCV) Care – Data emerging from an opt-out Emergency Department Blood-Borne Virus (BBV) Screening Programme – Dr. Sarah O’Connell
12.45-13.15	Lunch, Poster Viewing
13.15- 14.15	Janssen Sponsored Symposium:  Dr. Benoit Callendret,  Compound Development Team Leader, Ebola Vaccine, Janssen Pharmaceuticals.
14.15 – 15.00	Advances in Targeting Viral Reservoirs for HIV Cure/Remission Dr. Michael Miller, Senior Director of Clinical Virology at Gilead Sciences
15.00 – 15.15	A randomized, controlled study exploring factors associated with decision to undergo HIV screening – Dr. Paddy Mallon
15.15 – 15.30	Late Diagnosis of HIV in Northern Ireland – Dr. Suzanne Todd
15.30 – 15.45	Results from the SIMPle study; a cluster randomised intervention to improve the quality of antimicrobial prescribing for UTI in general practice –  Dr. Akke Vellinga
15.45- 16.00	Tea/Coffee, Poster Viewing
16.00 – 16.15	Mobile phones – A serious threat to infection control? Microbial analysis of personal mobile telephone devices within a major Trauma and Orthopaedic  unit – Dr. Aidan Dolan
16.15-16.30	NMDAR antibody production post Herpes Simplex Encephalitis – Dr. Sarah Geoghegan
16.30 – 17.30	Gilead Sponsored Symposium:  Dr Mas Chaponda, Royal Liverpool University Hospital, Dr Stefan Mauss, Center for HIV and Hepatogastroenterology, Dusseldorf
17.30 – 19.00	Reception

Saturday, 9^th May 2015

 

09.30 – 09.45	Detection of Staphylococcus aureus, Meticillin Resistant  Staphylococcus aureus and Coagulase-Negative  Staphylococci directly from Positive Blood Cultures by Real Time PCR – Maria Molloy
09.45 – 10.00	Detection of ESBL-producing E. coli and carbapenemase encoding genes in drinking-water sources  – Dr. Dearbháile Morris
10.00 – 10.40	Stem Cell Transplantation to Eradicate HIV Dr. Timothy Henrich, Harvard University, Brigham & Women’s Hospital
10.40 – 11.00	Coffee/tea, Poster Viewing
11.00- 12.00	Abbvie Sponsored Symposium:  Prof. Yazdan Yazdanpanah, Bichat Hospital, INSERM, Paris Diderot University Dr. Ciaran Bannan, St. James’s Hospital, Dublin
12.00 – 12.15	Factor associated with invasive pneumococcal disease in HIV-infected adults in the era of HAART – Dr. Corinna Sadlier
12.15 – 12.30	The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection – Dr. Jane O’Halloran
12.30 – 12.45	Environmental Determinants and Distribution of Verotoxigenic Escherichia coli (VTEC) Infection in Ireland, 2008–2013 – A Geostatistical Investigation – Dr. Coilín ÓhAiseadha
12.45 – 13.00	One Health: A Review of Human and Porcine Hepatitis E Seroepidemiology in Ireland  – Dr. Joanne O’Gorman
13.00 – 13.15	Antifungal Stewardship in the Intensive Care Unit at a UK tertiary referral teaching hospital – Dr. Eavan Muldoon
13:15	Prize Giving – Best Oral / Poster abstracts
13:30	Close of Meeting – Dr. Eoin Feeney, Secretary, IDSI